Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D01GCY
|
|||
Former ID |
DIB008984
|
|||
Drug Name |
NNC-26-0762
|
|||
Synonyms |
Growth hormone secretagogues, Novo Nordisk; NNC-26-0722
Click to Show/Hide
|
|||
Indication | Growth hormone deficiency [ICD-11: 5A61.3] | Terminated | [1] | |
Company |
Novo Nordisk A/S
|
|||
Structure |
Download2D MOL |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Growth hormone-releasing hormone receptor (GHRHR) | Target Info | Agonist | [2] |
KEGG Pathway | Neuroactive ligand-receptor interaction | |||
Reactome | G alpha (s) signalling events | |||
Glucagon-type ligand receptors | ||||
WikiPathways | GPCRs, Class B Secretin-like | |||
GPCR ligand binding | ||||
GPCR downstream signaling | ||||
GPCRs, Other |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800010046) | |||
REF 2 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800010046) |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.